AGP Executive Report
Last update: 2 hours agoProduct Safety: New Colorado research found only 1 in 7 cannabis products carried all required warnings, while more than half of flower products misstated THC levels. Medical Cannabis: Boots plans to offer private prescriptions in the UK for eligible patients aged 25 and over with conditions including chronic pain, anxiety and insomnia, alongside a study of patient outcomes. Hemp Rules: U.S. businesses are bracing for federal hemp-derived THC limits scheduled for Dec. 11, with retailers clearing shelves and some challenging the rules. CBD Research: A randomized trial found CBD did not improve severe behavioral problems in youths with intellectual disability, cautioning against using it for that purpose.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.